Evidence for Heightened Hexokinase II Immunoexpression in Hepatocyte Dysplasia and Hepatocellular Carcinoma

Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer

(2013) Krushna C. Patra et al.   CANCER CELL

Choline Kinase Alpha and Hexokinase-2 Protein Expression in Hepatocellular Carcinoma: Association with Survival

(2012) Sandi A. Kwee et al.   PLoS One

Nonalcoholic Steatohepatitis and Noncirrhotic Hepatocellular Carcinoma: Fertile Soil

(2012) Dawn Torres et al.   SEMINARS IN LIVER DISEASE

HCC and NASH: How strong is the clinical demonstration?

(2012) O. Rosmorduc et al.   Clinics and Research in Hepatology and Gastroenterology

Combined RNA Interference of Hexokinase II and 131I-Sodium Iodide Symporter Gene Therapy for Anaplastic Thyroid Carcinoma

(2011) J. E. Kim et al.   JOURNAL OF NUCLEAR MEDICINE

Reduced survival of patients with hepatocellular carcinoma expressing hexokinase II

(2011) Lei Gong et al.   MEDICAL ONCOLOGY

Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States

(2010) Avo Artinyan et al.   CANCER

TNM seventh edition: What's new, what's changed

(2010) Leslie H Sobin et al.   CANCER

Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection

(2010) Brad Q. Starley et al.   HEPATOLOGY

Clonality of nodular lesions in liver cirrhosis and chromosomal abnormalities in monoclonal nodules of altered hepatocytes

(2010) Li Gong et al.   HISTOPATHOLOGY

Towards a knowledge-based Human Protein Atlas

(2010) Mathias Uhlen et al.   NATURE BIOTECHNOLOGY

Tissue Microarray : A rapidly evolving diagnostic and research tool

(2009) NazarM.T. Jawhar   ANNALS OF SAUDI MEDICINE

Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005

(2009) Sean F. Altekruse et al.   JOURNAL OF CLINICAL ONCOLOGY